Emergency management of patients with bleeding disorders: Practical points for the emergency physician

Bowman, 2008, Generation and validation of the condensed MCMDM-1VWD bleeding questionnaire for von Willebrand disease, J Thromb Haemost, 6, 2062, 10.1111/j.1538-7836.2008.03182.x Rodeghiero, 2010, ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders, J Thromb Haemost, 8, 2063, 10.1111/j.1538-7836.2010.03975.x Pryzdial, 2018, Blood coagulation dissected, Transfus Apher Sci, 57, 449, 10.1016/j.transci.2018.07.003 Gailani, 2011, A cofactor for factor XI activation, Blood, 118, 6730, 10.1182/blood-2011-10-385336 Franchini, 2017, Acquired hemophilia A: a review of recent data and new therapeutic options, Hematology, 22, 514, 10.1080/10245332.2017.1319115 Hay, 2006, The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation, Br J Haematol, 133, 591, 10.1111/j.1365-2141.2006.06087.x Charlebois, 2018, Management of acquired hemophilia A: review of current evidence, Transfus Apher Sci, 57, 717, 10.1016/j.transci.2018.10.011 Bowman, 2009, Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire, J Thromb Haemost, 7, 1418, 10.1111/j.1538-7836.2009.03499.x Lee, 2018, Inherited platelet functional disorders: general principles and practical aspects of management, Transfus Apher Sci, 57, 494, 10.1016/j.transci.2018.07.010 Rand, 2018, Laboratory diagnosis of inherited platelet function disorders, Transfus Apher Sci, 57, 485, 10.1016/j.transci.2018.07.009 Srivastava, 2013, Guidelines for the management of hemophilia, Haemophilia, 19, e1, 10.1111/j.1365-2516.2012.02909.x Hanley, 2017, Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: a United Kingdom Haemophilia Centre Doctors’ Organisation (UKHCDO) guideline, Haemophilia, 23, 511, 10.1111/hae.13201 Poon, 2018, Hemophilia, BMJ Best Pract Fullerton, 2011, Evidence-based emergent management of bleeding disorders, Pediatr Emerg Med Pract, 8, 1 Schwartz, 2015, Hemophilia von Willebrand disease in children: emergency department evaluation and management, Pediatr Emerg Med Pract, 12, 1 Franchini, 2018, Non-factor replacement therapy for haemophilia: a current update, Blood Transfus, 16, 457 James, 2007, Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease, J Thromb Haemost, 5, 1165, 10.1111/j.1538-7836.2007.02563.x Revel-Vilk, 2003, Desmopressin (DDAVP) responsiveness in children with von Willebrand disease, J Pediatr Hematol Oncol, 25, 874, 10.1097/00043426-200311000-00010 Archer, 2015, The utility of the DDAVP challenge test in children with low von Willebrand factor, Br J Haematol, 170, 884, 10.1111/bjh.13331 Siew, 2014, Desmopressin responsiveness at a capped dose of 15 mug in type 1 von Willebrand disease and mild hemophilia A, Blood Coagul Fibrinolysis, 25, 820, 10.1097/MBC.0000000000000158